Dallah Healthcare Company (TADAWUL:4004)

Saudi Arabia · Delayed Price · Currency is SAR

117.20

+2.60 (2.27%)

Mar 24, 2026, 12:55 PM AST

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Facilities and Pharmacies	3.92B	3.05B	2.81B	2.37B	1.97B
Medical Facilities and Pharmacies Growth	28.21%	8.70%	18.65%	20.39%	-
Distribution of Pharmaceutic Products	151.58M	151.94M	133.40M	120.08M	138.29M
Distribution of Pharmaceutic Products Growth	-0.23%	13.89%	11.10%	-13.17%	-
Total	4.07B	3.21B	2.94B	2.49B	2.11B
Total Growth	26.86%	8.93%	18.28%	18.18%	-

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Kingdom of Saudi Arabia	4.07B	3.21B	2.94B	2.49B	2.11B
Kingdom of Saudi Arabia Growth	26.86%	8.93%	18.28%	18.18%	59.69%
Total	4.07B	3.21B	2.94B	2.49B	2.11B
Total Growth	26.86%	8.93%	18.28%	18.18%	59.69%

Source: S&P Global Market Intelligence.